Skip to main content
Caplight Logo









QUALIblood SA

QUALIblood SA

Private
LiègeHealthcare & Life Scienceshttps://www.qualiblood.eu/

Last Round

VC Round

Feb 14, 2025

Company Overview

QUALIblood SA is a healthcare company that provides specialized bioanalytical services, including hemostasis and biomarker analysis, to support pharmaceutical and biotechnology companies in drug development from preclinical to post-market phases.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Biotechnology, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

contract research organizationCRObiomarker analysishemostasis testingclinical trial supportbioanalytical servicesthrombosis researchbiobankhemocompatibility testingdrug safety testinglab servicesclinical study managementin vitro diagnosticIVDanalytical method development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

QUALIblood SA Comparables

Compare QUALIblood SA with similar companies based on industry and business-model similarity.

QUALIblood SA comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HaemoScan BV
84%
Immuneed
82%
Diagnostica Stago
74%

QUALIblood SA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 14, 2025
SeedNov 15, 2017

QUALIblood SA Investors

Notable investors and investment history

QUALIblood SA investors
InvestorRounds
NoshaqSeed, VC Round
Namur InvestSeed, VC Round
Walloon Region (Belgium)VC Round
UNamur VentureSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2025

    Monthly visitors increased 39% MoM, from 295 to 410.

  • Feb 14, 2025

    $2.28M round led by Namur Invest and Noshaq.

QUALIblood SA Filings

Explore SEC and related filing metadata, where available.

QUALIblood SA filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about QUALIblood SA's valuation, stock price, and market status.

Is QUALIblood SA a public or private company?

QUALIblood SA is a private company.

What is the current stock price of QUALIblood SA?

QUALIblood SA is a private company with no public stock price. Caplight tracks QUALIblood SA's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is QUALIblood SA worth (valuation)?

Valuation information for QUALIblood SA is not publicly available.

Can I buy QUALIblood SA stock?

QUALIblood SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was QUALIblood SA's last funding round?

QUALIblood SA's most recent funding round was VC Round on February 14, 2025.

Who are the main investors in QUALIblood SA?

Key investors in QUALIblood SA include Noshaq, Namur Invest, Walloon Region (Belgium), UNamur Venture.

Will QUALIblood SA IPO soon?

No public IPO plans have been announced for QUALIblood SA.

How can I track QUALIblood SA secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor QUALIblood SA's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLiège
Employee Range2
Year Founded2017
Last FundingFeb 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?